Artificial Sweetener Sucralose May Reduce Effectiveness of Cancer Immunotherapy
Emerging research indicates that the artificial sweetener sucralose may reduce the effectiveness of cancer immunotherapy by altering gut microbiota and immune cell function. Learn what this means for cancer patients and their dietary choices.
Artificial Sweetener Sucralose and Cancer Immunotherapy
Artificial sweeteners, commonly used to reduce calorie intake in diet foods and beverages, have raised health concerns, including links to gastrointestinal issues, metabolic problems, and potential cancer risks. Recent research suggests that sucralose, one of the most popular sweeteners, may impair cancer immunotherapy effectiveness.
Studies demonstrate that sucralose alters gut microbiota, decreasing bacteria that produce the amino acid arginine, crucial for immune cells to attack cancer. Experiments in mice showed increased tumor growth and diminished T-cell activity when fed high sucralose levels. Additionally, human studies linked high sucralose intake with poorer responses to immunotherapy in lung and melanoma cancers.
Experts warn that consuming large quantities of sucralose, such as through diet sodas, could compromise cancer treatments. Supplementing with arginine or citrulline might counteract these effects, offering a potential strategy for patients. Researchers advocate for further investigations but currently recommend minimizing artificial sweetener intake during immunotherapy treatments.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Questions Arise Over Citations in 'Make America Healthy Again' Report
A White House health report faces scrutiny after it was revealed that several cited studies are nonexistent, raising concerns about its credibility and scientific accuracy.
Exploring How Parkinson's Medication Influences Brain Activity and Treatment Effectiveness
Innovative brain imaging techniques are shedding light on how Parkinson's medication, levodopa, influences brain activity and treatment response, paving the way for personalized therapies.
Early Blood-Thinning Therapy Demonstrates Safety and Effectiveness for Stroke Patients
New research shows that initiating blood-thinning treatment within four days after a stroke caused by atrial fibrillation is safe and reduces the risk of recurrent strokes, potentially reshaping clinical guidelines.
Understanding the Formation of Wrinkles as Skin Buckles with Age
New research explains the physical process behind wrinkle formation as skin ages, highlighting how mechanical buckling contributes to skin aging and emphasizing the importance of sun protection.